AZURITY SOLUTIONS E-Z RX Trademark
Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for AZURITY SOLUTIONS E-Z RX with the United States Patent and Trademark Office. The USPTO has given the AZURITY SOLUTIONS E-Z RX trademark a serial number of 98438144. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, November 20, 2024. This trademark is owned by Azurity Pharmaceuticals, Inc.. The AZURITY SOLUTIONS E-Z RX trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Connecting qualified service providers with consumers in the nature of patient support services, namely, connecting patients with pharmacies for prescription drug access and medical cost management in the field of controlling medications costs; providing a discount savings program in the pharmaceutical field being administration of a program for enabling participants to obtain discounts on products
Providing medical information in the field of prescription drugs
General Information
| Serial Number | 98438144 |
| Word Mark | AZURITY SOLUTIONS E-Z RX |
| Filing Date | Thursday, March 7, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, November 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
Trademark Statements
| Pseudo Mark | AZURITY SOLUTIONS EASY PRESCRIPTION |
| Goods and Services | Connecting qualified service providers with consumers in the nature of patient support services, namely, connecting patients with pharmacies for prescription drug access and medical cost management in the field of controlling medications costs; providing a discount savings program in the pharmaceutical field being administration of a program for enabling participants to obtain discounts on products |
| Goods and Services | Providing medical information in the field of prescription drugs |
| NOT AVAILABLE | "SOLUTIONS" and "RX" |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 7, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, March 25, 2022 |
| First Use In Commerce Date | Friday, March 25, 2022 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 7, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, March 25, 2022 |
| First Use In Commerce Date | Friday, March 25, 2022 |
Trademark Owner History
| Party Name | Azurity Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 7, 2024 | NEW APPLICATION ENTERED |
| Sunday, July 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 8, 2024 | ASSIGNED TO EXAMINER |
| Saturday, August 17, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, August 17, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, August 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 14, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 14, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 14, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 14, 2024 | EXAMINERS AMENDMENT E-MAILED |
